HaDEA has published a Prior Information Notice (PIN) for a call for tenders to be funded under the EU4Health 2023 Annual Work Programme.
Biosimilar medicines have a similar efficacy and safety compared with their reference medicines and hold the potential to achieve significant savings for health systems and improve access to medicines for patients. Still, barriers remain and, to a certain extent, impede their successful entry into the market and uptake by health systems.
This call for tenders aims to support national authorities in implementing policies and practices that improve biosimilar competition to contribute to the accessibility, affordability and availability of medicines for patients in the EU.
Estimated budget: €1 500 000
EU4Health, with a budget of €5.3 billion, is the fourth and largest of the EU health programmes. The EU4Health programme goes beyond an ambitious response to the COVID-19 crisis to address the resilience of European healthcare systems. The programme provides funding to national authorities, health organisations and other bodies through grants and public procurement, contributing to a healthier Europe.
HaDEA manages the vast majority of the total EU4Health budget and implements the programme by managing calls for proposals and tenders from 2021 to 2027.
- Publication date
- 11 September 2023
- European Health and Digital Executive Agency
- Programme Sector
- EUFundedHealthUnionPublic healthTendering